Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cannataro

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Chemico-Biological Interactions|January 11, 2026
Upregulation of ACHE and BACE2 genes by Oleacein in Alzheimer's Disease and NeuroblastomaNicoletta Polerà, Giada Juli, Giuseppe Agapito, et al.
Oncotarget|June 10, 2015
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myelomaMaria Teresa Di Martino, Pietro Hiram Guzzi, Daniele Caracciolo, et al.
Molecular Biosystems|December 22, 2010
Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cellsGiovanni Nassa, Roberta Tarallo, Pietro H Guzzi, et al.
Proteomics|December 25, 2010
A large set of estrogen receptor β-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cell nucleiGiovanni Nassa, Roberta Tarallo, Concetta Ambrosino, et al.
Cancer Letters|August 1, 2008
A proteomics approach to identify changes in protein profiles in serum of Familial Adenomatous Polyposis patientsBarbara Quaresima, Telma Crugliano, Marco Gaspari, et al.
Biomedicines|May 28, 2022
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and PharmacogenomicsNicoletta Staropoli, Mariamena Arbitrio, Angela Salvino, et al.
British Journal of Haematology|April 27, 2011
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profilingMaria T Di Martino, Mariamena Arbitrio, Pietro H Guzzi, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2015
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysisMariamena Arbitrio, Maria Teresa Di Martino, Vito Barbieri, et al.
Oncotarget|March 13, 2013
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myelomaMaria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, et al.
Clinical Pharmacology and Therapeutics|February 11, 2019
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control StudyMariamena Arbitrio, Francesca Scionti, Emanuela Altomare, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Chemico-Biological Interactions|January 11, 2026
Upregulation of ACHE and BACE2 genes by Oleacein in Alzheimer's Disease and NeuroblastomaNicoletta Polerà, Giada Juli, Giuseppe Agapito, et al.
Oncotarget|June 10, 2015
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myelomaMaria Teresa Di Martino, Pietro Hiram Guzzi, Daniele Caracciolo, et al.
Molecular Biosystems|December 22, 2010
Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cellsGiovanni Nassa, Roberta Tarallo, Pietro H Guzzi, et al.
Proteomics|December 25, 2010
A large set of estrogen receptor β-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cell nucleiGiovanni Nassa, Roberta Tarallo, Concetta Ambrosino, et al.
Cancer Letters|August 1, 2008
A proteomics approach to identify changes in protein profiles in serum of Familial Adenomatous Polyposis patientsBarbara Quaresima, Telma Crugliano, Marco Gaspari, et al.
Biomedicines|May 28, 2022
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and PharmacogenomicsNicoletta Staropoli, Mariamena Arbitrio, Angela Salvino, et al.
British Journal of Haematology|April 27, 2011
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profilingMaria T Di Martino, Mariamena Arbitrio, Pietro H Guzzi, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2015
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysisMariamena Arbitrio, Maria Teresa Di Martino, Vito Barbieri, et al.
Oncotarget|March 13, 2013
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myelomaMaria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, et al.
Clinical Pharmacology and Therapeutics|February 11, 2019
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control StudyMariamena Arbitrio, Francesca Scionti, Emanuela Altomare, et al.
Pageof 9